Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study.

Idolazzi, L

Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study. [electronic resource] - Bone Oct 2017 - 144-149 p. digital

Publication Type: Clinical Trial; Journal Article

1873-2763

10.1016/j.bone.2017.07.004 doi


Adolescent
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Bone and Bones--drug effects
Child
Diphosphonates--therapeutic use
Female
Humans
Italy
Male
Osteogenesis Imperfecta--drug therapy